| Patient | Clara Barton |
|---|---|
| Date of birth | 1821-12-25 |
| Identifiers | MRN HR-NI024-SYN-TD; SSN (made up) 000-24-3357 |
| Document date | 1874-10-13 |
| Author | Eleanor Whitcombe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic preventive visit; no new complaints. [S]
Ms. Barton is a 52-year-old nurse and relief-agency director with recurrent major depression, in remission on sertraline 100 mg for about four months, who comes for her periodic preventive visit. She completed the health risk assessment before the visit. Her back pain settled within two weeks of the July visit, and she took ibuprofen for five days. She has finished her course of cognitive behavioral therapy and attends a monthly peer support group for relief workers. She works about 45 hours a week, sleeps about seven hours, and walks most days. She has not been deployed and has agreed with her board that she will not return to field work before the spring. She has had no suicidal thoughts. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 52 |
| Safety events | No falls, emergency visits, or hospital stays this year |
| Medicines | Sertraline 100 mg daily without missed doses; ibuprofen for five days in July; no supplements |
| Active conditions | Recurrent major depression in remission; back strain resolved |
| Functional status | Full duties at about 45 hours a week; independent in all activities |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, much better than in January |
| Psychosocial | Sees friends weekly; monthly peer support group; weekly services with her faith community |
| Tobacco | Never used tobacco |
| Alcohol and drugs | One glass of wine a week (AUDIT-C 1); no other drug use |
| Physical activity | Brisk walking about 150 minutes a week |
| Nutrition | Regular meals again; weight back to her usual |
| Sleep | About seven hours a night |
| Activities of daily living | Independent |
| Instrumental activities of daily living | Independent |
| Home safety | Smoke detectors working; no firearms in the home; medicines stored in a closed cabinet |
| Work | 45-hour week; delegates the families' correspondence; no deployment planned before the spring |
| Hearing and vision | No concerns; eye examination last year |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight back to her usual; no fever or fatigue |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing loss or dental pain |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No heartburn, change in bowel habit, or black stools |
| Genitourinary | Negative | No urinary symptoms; postmenopausal for about two years with no bleeding |
| Musculoskeletal | Negative | Back pain resolved |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Negative | No headaches, numbness, or weakness |
| Psychiatric | Negative | Mood good; PHQ-9 3 with item 9 scored 0; GAD-7 2; no suicidal thoughts |
| Breast | Negative | No lumps, pain, or nipple discharge |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1874-01-20 to 1874-03-03 | completed | S |
| Sertraline 100 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1874-03-03 | active | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth up to three times a day with food for no more than 7 days | One tablet up to three times a day with food, for no more than 7 days | Oral route | 1874-07-27 to 1874-08-02 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1874-10-13 | Body height | 152 | cm | S |
| 1874-10-13 | Body weight | 52 | kg | S |
| 1874-10-13 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1874-10-13 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1874-10-13 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1874-10-13 | Heart rate | 68 | /min | S |
| 1874-10-13 | Respiratory rate | 14 | /min | S |
| 1874-10-13 | Body temperature | 36.6 | Cel | S |
| 1874-10-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1874-10-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1874-10-13 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | {score} | S | ||
| 1874-10-13 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 1874-10-13 | Cholesterol [Mass/volume] in Serum or Plasma | 196 | mg/dL | <=199 mg/dL | Normal | S |
| 1874-10-13 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 64 | mg/dL | >=50 mg/dL | Normal | S |
| 1874-10-13 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 112 | mg/dL | <=129 mg/dL | Normal | S |
| 1874-10-13 | Triglyceride [Mass/volume] in Serum or Plasma | 98 | mg/dL | <=149 mg/dL | Normal | S |
| 1874-10-13 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
Vital signs recorded on 1874-10-13; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 52.0 kg, BMI 22.5 |
| Eyes | Pupils equal and reactive |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm at 68 per minute; no murmur; no edema |
| Respiratory | Clear |
| Breast | No masses, skin changes, or axillary nodes |
| Abdomen | Soft and non-tender; no masses |
| Back | Full, painless range of motion |
| Skin | No suspicious lesions |
| Mental status | Bright, engaged, and humorous; euthymic; no suicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Major depressive disorder, recurrent, moderate (moderately severe symptoms at intake), after a prolonged humanitarian deployment; synthetic modern diagnosis linked to her documented periods of depression and nervous prostration | active | confirmed | F33.1 | S — Synthetic modern diagnosis. Her periods of depression and nervous prostration are documented in her own words (D); calling them major depression is a retrospective interpretation (R), and no diagnosis was made in her lifetime. |
| Occupational burnout after eighteen months leading field medical relief in a war zone | active | confirmed | Z73.0 | S — Synthetic contributing factor echoing her documented exhaustion after wartime relief work; burnout is an occupational phenomenon, not a mental disorder. |
| Acute low back strain after lifting supply crates, without red flags or radicular signs; resolved | resolved | confirmed | S39.012A | S — Synthetic strain at an unscheduled visit, chosen to teach NSAID and SSRI bleeding risk and activity advice during depression continuation treatment; it does not echo any documented injury. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 118/72 mmHg |
| Cholesterol and statin decision | Completed today | Total cholesterol 196, HDL 64, LDL 112, triglycerides 98 mg/dL; ten-year risk about 1.5 percent, so no statin; repeat in five years |
| Diabetes screening | Completed today | HbA1c 5.4 percent; repeat in three years if risk factors develop |
| Breast cancer screening | Ordered | Last mammogram before her deployment, more than two years ago; biennial screening from 40 to 74; booked for next week |
| Cervical cancer screening | Up to date | HPV and cytology co-test negative three years ago, before deployment; next due in two years |
| Colorectal cancer screening | Ordered | No prior screening; options discussed and she chose colonoscopy, which is booked |
| Osteoporosis screening | Not indicated | Postmenopausal and under 65; FRAX ten-year major osteoporotic fracture risk 5.2 percent, below the threshold for bone density testing |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never used tobacco |
| Depression screening and monitoring | Completed today | PHQ-9 3 in continuation treatment; item 9 scored 0 |
| Anxiety screening | Completed today | GAD-7 2 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 1 |
| Hepatitis C and HIV screening | Up to date | Both negative at her agency's occupational health screening after her return, before this year's care began |
| Hepatitis B | Up to date | Vaccinated as a nurse, with immunity documented by her occupational health service |
| Influenza vaccine, this season | Completed today | Given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; a single dose is recommended for adults 50 and older |
| Recombinant zoster vaccine | Completed today | Dose 1 given today; dose 2 in two to six months |
| COVID-19 vaccine, this season | Due | Recommended; she will have it at her workplace clinic next week |
| Tetanus, diphtheria, and pertussis booster | Up to date | Tdap before her deployment, two years ago |
| Dental examination | Due | No dental visit since her return; she will book one |
Immunizations given today: Influenza vaccine, 1874-1875 season; Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]
Guideline basis: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Mammogram next week and colonoscopy as booked. Second zoster dose in two to six months. Depression review with PHQ-9 in about two months. Next preventive visit in one year. [S]
Voluntary advance care planning discussion of about 20 minutes, with her consent. She named a health care agent, a close friend from her relief work, and completed a health care proxy form; the agent is recorded in the chart and is not named here. She said that what matters most to her is being useful to others and staying independent. She wants full treatment for reversible illness. She asked that her mental health history be shared with any future treating clinician so that her care can continue without a gap, and she agreed to keep a copy of her safety plan with her proxy form. She chose not to record other specific treatment preferences today. The plan will be revisited yearly and before any future deployment. [S]